of the project were the same as those in the Kagoshima Study.
We obtained permission to use and analyze these data from the ethics committees of the National Hospital Organization Kagoshima Medical Center under the condition that confidentiality regarding all personal data would be maintained, and that all subjects gave their written informed consent.
Physical and Blood Biochemical Parameters
The parameters examined included height, weight, waist circumference, systolic and diastolic blood pressures (BPs), high-density lipoprotein (HDL)-cholesterol, triglycerides, fasting glucose, and fasting insulin.
The heights, weights and waist circumferences of the children were measured at each home doctor's clinic in the Kagoshima Study or by nurses at the elementary school in the Kirishima Study. Height was measured without socks and shoes, and weight was measured while the children wore only underclothing. Height was measured to the nearest 0.1 cm, and weight to the nearest 0.1 kg. Body mass index (BMI) was calculated as (weight in kg)/(height in m) 2 . A BMI SD score was calculated using the 1990 reference data for BMI in Japan. 18 BP was measured 3 times and the mean value of the last 2 measurements was used. Waist circumference was measured to the nearest 0.1 cm at the umbilical level.
Blood samples were collected in the morning after an overnight fast at each clinic (in the Kagoshima Study) or at the elementary school (in the Kirishima Study) and examined at the Laboratory Center of the Kagoshima City Medical Association Hospital in the Kagoshima Study or at a commercial laboratory (SRL Inc, Tokyo, Japan) in the Kirishima Study. Serum cholesterol was determined by the cholesterol oxidase-peroxidase method. Triglycerides were determined by the glycerol kinase-glycerol-3-phosphate oxidase-peroxidase method. Insulin concentrations were measured by chemiluminescence immunological assay. The homeostasis model assessment (HOMA) of insulin resistance (HOMA-IR) was calculated as follows: [fasting insulin ( U/ml)] × [fasting glucose (mg/dl)]/405.
Among predictors of MS, adiponectin, leptin, desacyl ghrelin, high sensitivity CRP (hs-CRP), and resistin were measured at the laboratory (SRL Inc, Tokyo, Japan); these 5 predictors are hereafter collectively called adipokines. Adipokines were measured using a Human Adiponectin ELISA kit ® (Otsuka Pharmaceutical Inc, Tokyo, Japan), a Human Leptin RIA kit ® (Linco Research Inc, St Charles, MO, USA), a Desacyl Ghrelin ELISA kit ® (Mitsubishi Kagaku Iatron Inc, Tokyo, Japan), N-Latex CRP II ® (Dade Behring Inc, Marburg, Germany), and a Human Resistin ELISA kit ® (BioVender Laboratory Medicine, Modrice, Czech Republic).
Definition of Obesity, Individual CV Risk Factors and MS
Obesity was defined as a BMI of ≥ the 95 th percentile for age and sex based on Japanese reference data in 1990 (Table 1) . 18 MS was defined using the newly established criteria by a Task Force financed by Health and Labour Science Research Grants in Japan. 19 The criteria set out that a person can be diagnosed as having MS when there is abdominal obesity plus any 2 of 3 individual factors: dyslipidemia (raised triglyceride level and/or reduced HDLcholesterol), hypertension, and raised fasting plasma glucose. Each CV risk factor was defined by the same criteria:
abdominal obesity (waist circumference ≥75 cm and/or waist/height ratio ≥0.5 for elementary school children), elevated BPs (systolic BP ≥120 mmHg and/or diastolic BP ≥70 mmHg), low HDL-cholesterol levels (<40 mg/dl), high fasting serum triglyceride levels (≥120 mg/dl), and high fasting serum glucose levels (≥100 mg/dl).
Statistical Analysis
Variables that were not normally distributed were log transformed. The statistical significance of differences in mean values between groups was assessed using the MannWhitney test; that for prevalence of MS was based on Fisher's exact probability test. To identify adipokines that are predictive of the accumulation of CV risk factors in normal weight, obese, and the entire group of subjects, multivariate regression analysis was performed using the number of CV risk factors as a dependent variable, and adipokine levels, age and gender as independent variables, using SPSS 15.0J software (Tokyo, Japan). To identify adipokines predictive of the presence of MS in obese and the entire group of subjects, logistic regression analysis was performed using the presence or absence of MS as a dependent variable, and adipokine levels, age and gender as independent variables. The logistic regression analysis was not performed in the normal weight subjects because of a very small number of the subjects with the MS (3 out of 109 subjects, 2.8 %). A level of p<0.05 was considered statistically significant.
Results
Gender differences were present in waist circumference, waist/height ration, and systolic BP in both normal weight and obese groups, in fasting blood glucose and leptin in the normal weight group, and in adiponectin, hs-CRP and the number of CV risk factors in the obese group; however, the BMI SD score was similar between genders in each group (Table 2) . Differences in the mean values of the following variables between normal weight and overweight groups were strongly significant: waist circumference, waist/height ratio, systolic and diastolic BPs, triglycerides, fasting insulin, HOMA-IR, adiponectin, leptin, hs-CRP, and the number of CV risk factors ( Table 2 ). The prevalence of MS was 2.8 and 7.1% in normal weight and obese children, respectively (Table 2) .
Multivariate regression analyses revealed that high leptin was independently predictive of the accumulation of CV risk factors in normal weight, obese, and the entire group of subjects (Table 3) . High hs-CRP levels in normal weight subjects and low adiponectin levels in obese and the entire group of subjects were also independently predictive of the accumulation of CV risk factors. Logistic regression analy- Tables 2,3 .
ses showed that a high leptin level was predictive of the presence of MS in obese and the entire group of subjects (Table 4) . Leptin levels were greatly increased when children of normal weight status developed 1 CV risk factor (Fig 1a) . The difference in leptin level between subjects with no risk factors and 1 risk factor was highest among neighboring subgroups. Adiponectin levels were also decreased significantly when boys developed any 1 CV risk factor (Fig 1b) .
Discussion
The present study showed that high leptin was independently predictive of the accumulation of CV risk factors in normal weight, obese, and the entire group of subjects. High CRP in normal weight subjects and low adiponectin in obese and the entire group of subjects were also independently predictive of the accumulation of CV risk factors. A high leptin level was predictive of the presence of MS in obese and the entire group of subjects.
The levels of adipokines have been widely investigated in several conditions in both adult and pediatric populations to compare individuals with or without MS or diabetes mellitus, subjects showing evidence of weight change, and groups of lean and obese subjects. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Among the many studies involving children and adolescents in which measurements of a few cytokines were included, some reports have discussed the identification of predictive adipokines by regression analysis. Gilardini et al recently reported an association between the presence of MS and several biomarkers, including adiponectin, interleukin-18, plasminogen activator inhibitor 1, CRP, uric acid and fibrinogen. 10 These authors showed that a low adiponectin level was independently associated with the presence of MS in Caucasian obese children and adolescents with a mean age of 14 years. Liu et al reported that a low adiponectin level is independently associated with the presence of MS in adults ≥18 years of age. 5 In the present study, both high leptin and low adiponectin levels were independent predictors of the accumulation of CV risk factors. A high leptin level also emerged as the one significant predictor of the presence of MS. One of the reasons for the importance of leptin levels in the present study might be because of the inclusion of normal-weight children. The serum leptin level is known to be high in both children and adults with obesity and/or MS. 5, 7, 8 Studies that include only subjects with obesity and/or MS might diminish the importance of the leptin level. Analyses separately performed in the normal weight and obese subjects in the present study (Table 3) might support this hypothesis. The present study shows for the first time that both high leptin and low adiponectin levels are independently predictive of the accumulation of CV risk factors, and that high leptin is solely predictive of the presence of the MS in elementary school children.
Leptin and adiponectin levels worsened abruptly when children developed any 1 CV risk factor (Fig 1) . Among adult individuals with a given BMI, elevated levels of glucose-and lipid-related factors are more likely to be present in Asians and Aboriginals compared with Europeans. 20 Obesity-associated disorders arise in mildly and moderately obese adults in Japan. 21 An abrupt worsening of CV risk factors emerged from mild obesity in Japanese elementary school children. 22 These data indicate that primary prevention of the development of CV risk factors is extremely important among some ethnic groups.
The inflammatory process has been reported to be associated with the development of the MS. [11] [12] [13] The hs-CRP level was significantly elevated in subjects with MS both in youth 12 aged 12-17 years and in adults. 11, 13 The present study showed that a high hs-CRP level was an independent predictor of the accumulation of the CV risk factors in normal-weight children aged 6-12 years.
Gender difference was present in some levels of the entire group in the present study. Many studies have also reported a gender difference in the levels of waist circumference, 10,12 systolic BP, 13, 23 adiponectin, 10, 24 hs-CRP 13, 25 and the prevalence of the MS 26 in both pediatric and adult populations. The present study could not provide clear reason(s) for this rapid appearance of gender difference in children as young as those in elementary school and therefore this needs further investigation in the future.
The approach used in the present study had some limitations. We combined 2 cohorts: participants in a program to screen obesity-related CV risk factors and a group of healthy volunteers in a related program. However, both cohorts were residents of the same prefecture. Future studies should include both normal weight and obese children from the same cohort. Another limitation was the lack of age-and ethnicity-adjusted values for individual CV risk factors for Japanese children from data of relatively large cohorts. Projects to establish criteria for defining MS in Japanese children started 3 years ago; thus, age-and ethnicity-adjusted values for Japanese children and adolescents will be presented in the near future.
